ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000232.1|Hatomarubigin_1 # 3 # 371 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.675	BGC0000232.1|Hatomarubigin_1 	3	371	+	Loose	1150	23.0978	blaR1	32.56	3000217	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BlaZ beta-lactamase	GGCGAGCTGGTGCAGCGCGCCTCGCAGCAGTTGACCGAGCTGGTGCGCGGCGAGATGAAGCTGGCGCAGGCGGAGATGAAGGAGAAGGGCAAGCGCTACGGCAAGGGCGGTGGCCTGTTCGGCGGGGCTGGCGTCGTGGGCTTCCTGATGCTGCAGGCGCTGATCGCCACCGCGATCGCCGCGCTGGCGGTGCCGCTGCCGGTGTGGGCAGCGGCGCTGATCGTCACCGCGGTGCTGGGTGTGATCGCCGCGATCATGGCCATGAGTGGAAAGAAGCAGGTCGACCAGGCCGCGCCGGCCGCACCTGAGCAGATGATCGAGAACGTGAAAGCCGATGTGACCGAGATCAAGGAGAGTTCCCACCGATGA	GELVQRASQQLTELVRGEMKLAQAEMKEKGKRYGKGGGLFGGAGVVGFLMLQALIATAIAALAVPLPVWAAALIVTAVLGVIAAIMAMSGKKQVDQAAPAAPEQMIENVKADVTEIKESSHR	MTLPHILLSLVLITATILVIFFVRAVFYKQLSAKWRYHLWFLLITVLTLPFIPIHLLTGLSFFDQGRQQITPSAQKRFGFADQNEQWMVDFGTSVSRFDDTFIHAVFVSIWIGGMIFFLLLTLYHYAKLQRLVKAASRIQNQKVENAFSDCMAELQITNKLTNLESPAIQTPMTFGWLKTYILLPKNIELYLSDDEIRHVLLHELHHYKSKHIKVNYIFVVYQIVYWFHPLVWKAFKEMRLDRELACDTEVLLTLGQREYKAYGQTIMRFLERNSRFLYLTNPLHSSKKAFKNTKSYNIAFFYWRVKSGAQLKKPWVVFAGLTRFCIAQFPFLTATAVSTERYQFDESQAVVEDYSTYFAGNEGSFVLYSLTSDQFEIYNKEKSVRRVSPNSSYKIYTALMALELGVIGRDDSWLEWDGVEYEDEAWNSGQDLKSAMSQSVTWYFQELDERIKQRNIQSFVNQLDYGNKDLSGGLNHYWLESSLKISPVEQVELLHSFYTNQLDFKEEHVQFVKEVMKLEENQKGTLYGKTGTGIVNGHAINGWFIGFVETETDTYFFATNIQQKIMHMEARLLKSLYPFCQAKEFID	20.75	gnl|BL_ORD_ID|1900|hsp_num:0	2063			1518	1638	
BGC0000232.1|Hatomarubigin_2 # 368 # 850 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.733	BGC0000232.1|Hatomarubigin_2 	368	850	+	Loose	950	24.6386	msrE	22.06	3003109	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGACCCAGCCGCCTCACGACGAGCCCACCGCCTCCAGCCCCGACGAGCTGCGCGAGCAGGTCGAGCAGACCCGCGAAGAGCTCGGGCAGACGGTCGAGGCGCTCGCAGCCAAGACCGACGTCCAGGCGCGCGCCCAGGAGAAGGCCGCCGAGGTCAAGGAGCAGGCCACCGCCAAGGCCGGCGAGCTGAAGGAGCAGGCCACGGTCAAGGCCGGGGAGCTGAAGGCGAAGGCCACCGACCTGGCGCACCAGGTGCAGGACAGGCTGCCCGACCCGGTCAAGGACAAAGCCGCCCAGGCCGCGGGGCAGGCCCGAACGAAGGCAGCCCAGGCCGGGCAGGTGTGGGAGGAGAAGGCGCCCGAGCCGCTGCGGCAGAAGACGGCCCAAGGGGCGCAGCTGGCGCGGGACAACCGCAAGGTGCTGCTGGCGGCCGCGGGCGTGGCCGTCGTGGTCTGGCTTGCCTGCCGTCGCCGGAAGGGGTGA	MTQPPHDEPTASSPDELREQVEQTREELGQTVEALAAKTDVQARAQEKAAEVKEQATAKAGELKEQATVKAGELKAKATDLAHQVQDRLPDPVKDKAAQAAGQARTKAAQAGQVWEEKAPEPLRQKTAQGAQLARDNRKVLLAAAGVAVVVWLACRRRKG	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	32.59	gnl|BL_ORD_ID|27|hsp_num:0	33			546	912	erythromycin
BGC0000232.1|Hatomarubigin_3 # 825 # 1124 # 1 # ID=1_3;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000232.1|Hatomarubigin_3 	825	1124	+	Loose	1900	23.8682	MexI	30.43	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGCCTGCCGTCGCCGGAAGGGGTGAGCCAGGGGGAAAGGATCCAAGATCGCCTATTAAGCCGGTCGGTCTGGCGCTCGGGGCCGTAAGCGGAATGGCCGCGGGAACGCTGTTCAAGCAGGCGTGGAAGATGCTGGGCCACGATGACGACGCCCCGGACGCCACCGACGAAGAACGCTCCTGGCGCGAGGTGCTGCTCGCCGCCACGCTGCAAGGGGCGATCTTCGCCGGAGTCAAAGCCGCCGTCGACCGGGCCGGCGCCACCGCCACCCGCCGCCTGACCGGCACCTGGCCCGGTTGA	MPAVAGRGEPGGKDPRSPIKPVGLALGAVSGMAAGTLFKQAWKMLGHDDDAPDATDEERSWREVLLAATLQGAIFAGVKAAVDRAGATATRRLTGTWPG	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	9.62	gnl|BL_ORD_ID|4683|hsp_num:0	1647			2925	3063	acriflavine; tetracycline; norfloxacin
BGC0000232.1|Hatomarubigin_4 # 1709 # 1915 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.691	BGC0000232.1|Hatomarubigin_4 	1709	1915	-	Loose	875	23.0978	tet(W/32/O)	30.3	3007124	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGACCATACGCCTGGCCGTGACCGGGGACGAGGCGCTGCTGATCGACGTGCAAGACCCGCGCCCGGACGTCCAGCTCAGCGAGGCCGCCAACGACGGTGAGAAGGGGAGCGGCCTGAAGTACGCACGTCTCCTGGGCGCGACGGTCAGCTGCTTCATGTCCGAGGACGCCCGCTGCAAGACGGCCTGCTGCCGGACGTCGGATTAG	MTIRLAVTGDEALLIDVQDPRPDVQLSEAANDGEKGSGLKYARLLGATVSCFMSEDARCKTACCRTSD	MNIINIGILAHVDAGKTTLTESLLYASGTISEPGSVEKGTTRTDTMFLERQRGITIQTAVTSFQWHSCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVLSARDGVQAQTRVLFHALRKLNIPTIIFINKIDQVDIDLEGVYQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDGLLEKYIAGEPISREELAREEQRRVQAASLFPVYHGSAKNGLGIQRLMDAVIGLFQPTKEQGRTALCGSVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSDAPFSMLRTTITPKTAEQRDRLLDALTQIADTDPLLCYEVDSITQEIILSFLGRVQLEVVSALLAEKYKIETAVKEPTVIYLERPLKVASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVMDGIRYGLEQGLCGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLELALKESGTQLLEPYLSFTLYAPQEYLSRAYHDAPKYCATIETAQIKKDEVVFTGEIPARCIQAYRTDLASYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDRVRHMFQKVM	10.64	gnl|BL_ORD_ID|4798|hsp_num:0	5794			651	750	tetracycline
BGC0000232.1|Hatomarubigin_6 # 3399 # 3656 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	BGC0000232.1|Hatomarubigin_6 	3399	3656	+	Loose	550	22.7126	LRA-2	40.0	3002485	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	GTGACAAGCCGGAGGGACGACGGCCGGGTCCGCCATCGCCGTGTGCTTCGCGGTGAATTTCCCGCGCGGGCCTTCCCGGTCGGCTATTCCGCTCAGCGCTTGCCTCGGCATCCCTCCCCCTCCGACCTTTCCCGCTCCGGCCTTTCAACCCCCATCCTCCCTGCCCAAAAGGGGTTTTTACGCCGCAGAACAGTGGCCATTTCCCGCTCGACCGACAACGGAACGACGTGGAGGAGACACGAATGCACAGCACCCTGA	MTSRRDDGRVRHRRVLRGEFPARAFPVGYSAQRLPRHPSPSDLSRSGLSTPILPAQKGFLRRRTVAISRSTDNGTTWRRHECTAP	MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYFVGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGGVAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGALRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASSFSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLASEG	28.15	gnl|BL_ORD_ID|1218|hsp_num:0	1324			534	609	
BGC0000232.1|Hatomarubigin_9 # 5250 # 5528 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.720	BGC0000232.1|Hatomarubigin_9 	5250	5528	-	Loose	600	22.3274	TriB	44.44	3003680	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGACGAGTCCGGCGAGCGTGTCCAGTTGTGGGAGTTCGCCCACGCCGAGAGGGGCTTCACCACGACCGCGGCCGGTCGCCCGGTGGTGCCGATGCGCCCCGACGTCATCGAGGCCGTACTCAGCCAGGCCATCGCCGACGACAGCCGGCCCACCGGCGACCGTGCCGCCGAGATCTGCAACGACGCCCGCACCGGCGACAGTCGCCACCCCCCGGCCAACCGCAGGATCAACAGGACCGCCGACACGCCCTCGGCCGGATCGAGGTTGACTCGGTGA	MDESGERVQLWEFAHAERGFTTTAAGRPVVPMRPDVIEAVLSQAIADDSRPTGDRAAEICNDARTGDSRHPPANRRINRTADTPSAGSRLTR	MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLGFRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQEELFARSVTAQARLDDARTRLKTSQASFDQAKAAVQQARDQLSYTRLVTDFDGVITTWHAEAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIRELGPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWVVDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR	25.84	gnl|BL_ORD_ID|2003|hsp_num:0	2193			534	615	triclosan
BGC0000232.1|Hatomarubigin_10 # 5627 # 6826 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.729	BGC0000232.1|Hatomarubigin_10 	5627	6826	+	Loose	500	28.8758	CPS-1	35.71	3003716	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CPS beta-lactamase	GTGGTGACCGGCCTCGGTGTGGTCGCCCCCAACGGACTCGGAGCCCAGGAGTACTGGGCGGCCGCACGGGTCGGCACGAGCGCGATAGGCCGGATCTCCCGCTTCGACCCGACCCAGTACCCCTCTCGGCTGGCCGGCGAGATCCACGGCTTCGTGGCCGAGGACCACCTGCCCAACCGGCTGCTGCCGCAGACCGACCGGATGACCCGGCTCGCGCTGGTGGCGGCGGACTGGGCGCTGGAGGACGCCGGCATCGACCCGCGGGAACTGCCCGCGTTCGACATGGGCGTTGTCACCTCCAGCGCCTCCGGCGGCTTCGAGTTCGGCCAGGGCGAGCTGCAACGGCTGTGGAGCCAGGGCAGCGAGTACGTGAGCGCGTACCAGTCCTTCGCCTGGTTCTACGCGGTCAACAGCGGCCAGATCTCCATCCGCCACAACATGCGCGGCCCCAGCGGCGTGGTCGTCAGCGACCAGGCGGGCGGACTGGACGCGGTCGCACAGGCGCGGCGGCAGATCCGCAGGGGCACGCCACTGATCGTCTCCGGTGGGGTGGACGCCTCGTTGTGCCCGTGGGGCTGGGTGGCCCAACTGACCAGCGGCCTGCTGAGCAGCGACGACGACCCGGCCACGGCGTACCTGCCGTTCGATCGCAGGGCCTCCGGGCACGTGCCGGGCGAGGGCGGCGCCATCCTCATCGTGGAGCGCCGGGACCTGGCCGCGGCGCGCGGCGCGCGCGTCTACGGCGAGATCGCCGGCTACGGCGCCACCTTCGACCCGCGTCCGGGCAGCGACCGTCCGCCGGCGCTGCGCGCGGCGATCGAGGCCGCGTTGGCCGACGCCGGCGCGGATGCCGCCGACGTGGACGTGGTCTTCGCCAACGGCGCGGCCATGCCGGAACTGGACCGGGTGGAGGCCGATGCGATCAACGCGGTCTTCGGTGCCCGGCAGGTGCCGGTCACCGTGCCCAAGACGGCAACGGGCTCGCTGTACTCCGGTGCTGCCGCGCTCGACCTGGCGACGGTCTTCCTCGCCATCGAGGAGGGCCTGATCCCGCCGACGGTGAACACCGAGCCCGACGAAGGTTACGGCCTGGACCTCGTGGTCGGCCGTCCGCGCACCGCCGAGATCCGTACGGCCCTCGTCCTGGCGCGCGGTCACCGGGGCTTCAACTCGGCGATGGTCGTGCGCTCCGCTGACTGA	MVTGLGVVAPNGLGAQEYWAAARVGTSAIGRISRFDPTQYPSRLAGEIHGFVAEDHLPNRLLPQTDRMTRLALVAADWALEDAGIDPRELPAFDMGVVTSSASGGFEFGQGELQRLWSQGSEYVSAYQSFAWFYAVNSGQISIRHNMRGPSGVVVSDQAGGLDAVAQARRQIRRGTPLIVSGGVDASLCPWGWVAQLTSGLLSSDDDPATAYLPFDRRASGHVPGEGGAILIVERRDLAAARGARVYGEIAGYGATFDPRPGSDRPPALRAAIEAALADAGADAADVDVVFANGAAMPELDRVEADAINAVFGARQVPVTVPKTATGSLYSGAAALDLATVFLAIEEGLIPPTVNTEPDEGYGLDLVVGRPRTAEIRTALVLARGHRGFNSAMVVRSAD	MRNLTLLFLLCLSFFGTAQTVTEPKNNPAEWSKDYEPFKIVGNLYYVGTYDLASYLIVTDKGNILINTGLADSYSTIKKNIEKFGFKYKDIKILTLTQAHYDHMGAMAQIKKETGAKLYVDEKDAAELKSGGKSDYEMGKYGVTFEPVHPDFLLKNNAKIKLGNTVLTLLHHPGHTKGSCSFLFETKEGNKNYKVLIANLPSIIIDHKFSDVKKYPTIQKDYGYTFEAMKKINFDVWVASHASQFDLHKKRKEGDSYNPKLFMDKENYFKRLKDLENDYLEKVKEDSAKK	137.59	gnl|BL_ORD_ID|2028|hsp_num:0	2231			315	441	
BGC0000232.1|Hatomarubigin_11 # 6866 # 7570 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.723	BGC0000232.1|Hatomarubigin_11 	6866	7570	+	Loose	450	25.409	AAC(2')-IIb	40.0	3003988	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	ATGCCTGTAGCCTCCGACGCCCCACCGGACTTCGGCCGTTCCGACGTCGAGGCGGTGGTGGTCACCACCGCCTCGCTGCCGAAACCGAACGCCGCGGAGCTCGCCGACACCGTGGCCGCGCGCTGGCAGGCCGGTCCGTGGCCGGCCGAGCAGGTGGCGCTGAGCGTGTTCATCGGCGGAGATGGCACCTCGGTGCTGACCTACGCGCAGTGGTCCTCGCGCGGCGCGCTGGAGGAGTCGCTGAGGGACCACGGGAGCGTGTCGTGGGCGAACGCCCCGGGCGCGCTGCTGGGCGAGGGCGCCGACAGCGGGGTGCGGACCACCGGGCCGCTGCCGTTCGGGATCTATCGCACGGTGCGCGGCACCGCGGTCACCGAGGAGAACCCGGTGCCGGTGAGTTTCCCGGTGGCGTTCTTCACGATGGCCGACGAGGCGTCGGCGGCGGCGTGGGTGGACGGCCTGCTGTCGGCGGAGGAGGAGAACGAGGGTGACGAGCGCGCCTACCCGGACGCCATCGCAGCCAACTTCCACGTCAGCCTGGACGGCACCCAGGTGCTGGTGCTGTCGGAGTGGCTCTCCGCGGAGGCTGCCTCGCAGCACATCGCCGACGTGTGGGACCCGATCCTGGCGCACTTCGGCGGCGACGCCGGCGCGCTGTACCGGCACCACACGACGCTCAACGCGCTGGAGAAGACAGCCGACTGA	MPVASDAPPDFGRSDVEAVVVTTASLPKPNAAELADTVAARWQAGPWPAEQVALSVFIGGDGTSVLTYAQWSSRGALEESLRDHGSVSWANAPGALLGEGADSGVRTTGPLPFGIYRTVRGTAVTEENPVPVSFPVAFFTMADEASAAAWVDGLLSAEEENEGDERAYPDAIAANFHVSLDGTQVLVLSEWLSAEAASQHIADVWDPILAHFGGDAGALYRHHTTLNALEKTAD	MNHRKGNEPTAAALMELHVLAMFTHDGNMQIRTINEPWPGEELAPRFFMGRTIDGSSICRFRHDVPEGIAGQLRALVEDEPIVTEEVLTRPKHFAAYMNLLRAEHYTSGPCYRIPDQTTQAKQTVRITPGNIREYSLTGFEWLTTEIDYDQPCVALIHENRVVSVCRSVRITERAHEAGLETSEEFRGRGYAAAVVAGWAIEVQKMGALALYSTLWGNSSSRRVANKLGLSYYGVNFTIS	97.50	gnl|BL_ORD_ID|2232|hsp_num:0	2524			108	183	kasugamycin
BGC0000232.1|Hatomarubigin_12 # 7573 # 9903 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0000232.1|Hatomarubigin_12 	7573	9903	+	Loose	550	225.328	Nocardia farcinica rox	42.93	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGCCGCGCGCAGGTCGGCCCCAGAAGGAAGGCCTGCCCGCGACCCGACCACCCCGATCGGCTGTGCCGCGACGTCGCGTGCCCGCGTCCAAGGAGTGCACCCAGTCATCATGGCTACTCGTCACCGAATCCTGGCTACTCGCCACCGCAGCGGTCGGCCCGTGCGCGGCGCGCCGCGGCTCCCGCCATCACGGTGGGCGCGGCTGGCCCGTCCAAGGTCCCGTCGCCGGCCGGCCGCCCACCGGGCCGCTCCCGCCACGGCATCCCCCGAAGCGGGGTGCTGACCCGATGAGCGGGCCGGAGAGGGGCGGCGCGCACGCCGGCGGGGGCCCGGTCGAGCCATATTCACACGCGCTGGAACCTGACGTGCTGATCGTCGGTGCCGGTCCGGCCGGGCTGTTGCTGGCCGGCGACCTGGCGTCCGACGGGGTGCGGGTGACGGTGGTGGATGCGCTCACCGAGCCGATGACCGAGTCACGTGCCTCGACCTTGCACGCGCGCACCATGGAGGTGCTGGCCGCGAGGGACCTGTTGGAGCGGCTGGGCCCGCCGCCGCCCGGTGGTCCCGGCCACTTCGGCGGCCTGCGGCTGGACCTGGCCGAGGCCGATCCGCAGCACCGGCACGCCGGGCAGTGGAAGTGCCCGCAGACGCTACTGGAGCGTGAACTCGCTCGGTGGTCAACCGAGTCGGGGGCACTGCTGCTGCGCGGGCACCGGCTCGTCGCGCTGACCCAGACCGCCCACCGGGTGGAGGTCGAGTTGAAGTCGGCCGACGGCTCCCGGGTCGCGGCACGGGCGCCCTACCTTGTCGGGTGCGACGGCGAACGCAGCACCGTACGGGAGCTGGCCGGCTTCACTCTGGCCGGCCGGAGCGCCGGGCGGGAGATGCTGCGGGCCGACGTCGCCGGCATCGACGTGCCTGACCGCCGCTTCGAGCGTCTGCCCCGGGGCATGGCGACAGCGGCCCGGTGGCCGGACGGCTCGACTCGGCTGATGGTGCACCTGTACGGCCACCGGCCGCAGCCGCGCTCGGGGCCGCCCTCCTTCGCCGAGGTCGCCGACGCGTGGGCCACGGTGACCGGCGAGGACGTCGGACACGGCACGCCGCTGTGGCTCAATGCGTTCGACGACACCAGCCGACAGGCCACCCGCTACCGGCAGGGCCGGGTCCTGCTGGCCGGCGACGCCGCGCACCTTCAGATGCCCGTCGGCGGCCAGGCGCTCAACCTCGGTCTGCAGGACGCCTCCGACCTGGGGGGCAAGTTGGCCGCGCGAGTGCTGGGGCGGGCCGGCGACGAGGTCCTGGAGAGCTACCACGACAGCCGTCATCCGGTGGGCGCGCGCACGCTGTCCAACATCCGCGCCCAGACACTGCTGCTCCTCGGCGACCAGCAGGTGGAGCCGCTGCGATCCATCTTCGGGGAGCTGCTGGAGGACCGGGCGGTCCGCCGCCACCTGGCCGGAATGATCAGCGGGCTCGACACGGCCGCACCGGAACCCGGCGTCCCGCGGCCGACACCCGCGCCGGCGCCCAGCCGGCCTCACCTGACACCTGAGAGGACCACCGTGAGCAGGCTCATCGACAAGACCGCGCTGGTAACCGGCTCCAGCCGGGGCATCGGGCGCGCCATCGCCACCCGACTGGCGGCCGAGGGCGCCTTGGTGGCCGTGCACTACGCCTCGAACGCCGACGCGGCCCTGGAGACCGTTGAGTTGATCGAGAAGGACGGCGGCCGGGCGTTCCCGGTGCGGGCCGAACTCGGCGCACCCGGCGACGTGCACCAGCTGTTCCTGGGCCTGGAGAAGGGCCTGAAGGAGCGGATCGGGGAGACCAGGCTCGACATCCTCGTCAACAACGCGGGGGCCATCACCCCGGTCGGCCAGCAGCCGGAGGACACCACCCCGGAGGAGTTCGACCACCTGTTCGCGGTCAACGCCAGGGCGCCGTTCTTCATCGTGCAGCGGGCACTCGGCATCATCCCCACCGGCGGCCGGATCATCAATATCTCCTCCGGTTTGACCCGGTTCTCCAACCCGGAGCAAACCGCCTACGCCATGACCAAGGGCGCCATCGAACAGCTGTCGCTGCACCTGGCCCGGCATCTGGCGCCACGGCTCATCACCGTCAACAGCGTCGCTCCCGGCATCACCGACAACGGCGGCGCCGTGTTCGACATCCCCGAGGCGGTGGAGCAAATGGCGCAGCTGTCGGCCTTCAAGCGGGTCGGCAAGGCCGAGGACGTCGCCGACGTGGTCACCTTCCTCGCCACCGACGAGGCGCGCTGGATCACCGGAGCTTTCATCGACGCCACCGGCGGCACGCTGCTGTAG	MPRAGRPQKEGLPATRPPRSAVPRRRVPASKECTQSSWLLVTESWLLATAAVGPCAARRGSRHHGGRGWPVQGPVAGRPPTGPLPPRHPPKRGADPMSGPERGGAHAGGGPVEPYSHALEPDVLIVGAGPAGLLLAGDLASDGVRVTVVDALTEPMTESRASTLHARTMEVLAARDLLERLGPPPPGGPGHFGGLRLDLAEADPQHRHAGQWKCPQTLLERELARWSTESGALLLRGHRLVALTQTAHRVEVELKSADGSRVAARAPYLVGCDGERSTVRELAGFTLAGRSAGREMLRADVAGIDVPDRRFERLPRGMATAARWPDGSTRLMVHLYGHRPQPRSGPPSFAEVADAWATVTGEDVGHGTPLWLNAFDDTSRQATRYRQGRVLLAGDAAHLQMPVGGQALNLGLQDASDLGGKLAARVLGRAGDEVLESYHDSRHPVGARTLSNIRAQTLLLLGDQQVEPLRSIFGELLEDRAVRRHLAGMISGLDTAAPEPGVPRPTPAPAPSRPHLTPERTTVSRLIDKTALVTGSSRGIGRAIATRLAAEGALVAVHYASNADAALETVELIEKDGGRAFPVRAELGAPGDVHQLFLGLEKGLKERIGETRLDILVNNAGAITPVGQQPEDTTPEEFDHLFAVNARAPFFIVQRALGIIPTGGRIINISSGLTRFSNPEQTAYAMTKGAIEQLSLHLARHLAPRLITVNSVAPGITDNGGAVFDIPEAVEQMAQLSAFKRVGKAEDVADVVTFLATDEARWITGAFIDATGGTLL	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	164.06	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1122	rifampin
BGC0000232.1|Hatomarubigin_16 # 12674 # 13300 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.676	BGC0000232.1|Hatomarubigin_16 	12674	13300	+	Loose	1000	28.8758	HelR	30.0	3007208	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	helicase-like RNA polymerase protection protein	ATGGGTTCGATCAGGGTGGAGGACGGCTACCTCTCGCTGTTCAACATCTTCCACATCGAAGGGGCACCCGGGCAGGACCGGCTGTTCGAGACGTTTCGCGGCCTACCCCCAGCCAAAGTCCAGCCGGGTCTCGTCTCGGGCAACATCCACCGCGGCACCGACGGCCGGTCCGTCCTCAACTACGCCCAGTGGGAGAGCCAGGCAGCCTACGACGCCTTCAGAGCCGAGACCGCAACCAAGGGCCGGCTCGACCAGGCCCTGACCTTCTCCCGGATGGACAGCGTCGCCACCGAGGTGGTCCACACCTGGCAGCCGGCCCCCCGGCTGTCGGTGGACGACGGCCTGCTCACGGCGGTCGTGCTGATCACCACCACCCCCGAGCACCAGGCCGAGGTGCTGAAGGAACTGGTCCAGGACGACCCGGCACTGGCCGACACACCAGGGTTCGTCTCCGACGCGGTGCACAGGGGCCTGTCCGGGGAACACGTCGTCAAATACGCCCAGTGGGAGGACGAGGCGGCCTTCCGGTCCTACCTCGGCAAGCAGCGGTCGCCGTCGGCAGTGGAGTACCTGATCAGCGTCGAGATCCACCTCAGCCGGCTCGAGTACGTGCGAGGCCGGTCGTGA	MGSIRVEDGYLSLFNIFHIEGAPGQDRLFETFRGLPPAKVQPGLVSGNIHRGTDGRSVLNYAQWESQAAYDAFRAETATKGRLDQALTFSRMDSVATEVVHTWQPAPRLSVDDGLLTAVVLITTTPEHQAEVLKELVQDDPALADTPGFVSDAVHRGLSGEHVVKYAQWEDEAAFRSYLGKQRSPSAVEYLISVEIHLSRLEYVRGRS	MRVLSSVDQLDGTSAFDLPDRLSAKTDPALIAADERHFSAIAKSLAETITELSDRLDATRKAPGGVGREAMDRDAEIHRLTGRLRTLRRFGLDLCLGRIVTADDAEPVYVGRLGLTDSTGRRLLVDWRSPAAEPFFAATHADPMGLTSRRRYRWTGGRVSDYWDEVFTADGLEEHAALDDQSAFIASLGSSRSPQMRDVLATIQADQDAIIRAGSRGTLVVDGGPGTGKTVVALHRSAHLLYADPRLGHRRGGVLFVGPHQPYLAYVADVLPSLGEEGVRTCTVRDLVAEGAGAAVERDAEVARLKSSADMVRAIEAAVRFYEEPPTQRMTVSTDWADVRLTADDWAEAFDAPEAGTPHNEAREQIWEELGSILLGKLGDEVPEEEFRRALRQDEELAGALHGAWPLLEAADLVGDLWSVPAYLRKCAPWLDREDVAKLQRADAQAWTVSDLPLLDAARQRLGDPEAARRRRRQQATVAAERARMADVIADVLAADDDGEGAVTMLRGQDLKDTLVDEAALTGVEPDLLAGPFAHIVVDEAQELSDAEWQMLLLRCPSRSFTIVGDRAQARHGFTESWEERLARVGLDRITVASLSINYRTPEEVMAEAEPAIRAALPDANVPTSVRSSGVPVLRGPVEELDTIVDEWLAANADGTACVIGAPRFRPGPRVRSLTPSLSKGLEFDLVVLVDPEDFGGGIEGAVDRYVAMTRATKQLVILTSS	28.81	gnl|BL_ORD_ID|4837|hsp_num:0	5819			462	612	rifampin; rifaximin; rifabutin
BGC0000232.1|Hatomarubigin_17 # 13297 # 14415 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.750	BGC0000232.1|Hatomarubigin_17 	13297	14415	+	Loose	1000	26.9498	MCR-4.4	38.46	3004696	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGACCGCCGCCGGCAGCTGGCCGGACCCCGCGGCGGTCCGGGTGACGGCCGAGTCCGCCGGCCGAGGCGCCGCCGAGGCGGACGCCTCGGGACGGATCGGCGCCGAGACCGTCGAGGCGCTGACGGCGGCCGGCTTCCCCAGCGCCTTCGTGCCCGAGCGCTGGGGTGGCGCGGACGCCACCTGCGGCGCGGTGGCCAAGGCGGTGGCGGAGATCGGCGCGGGCTGTGCGTCCGCGGCCTGGATCGCCTCGCTGCTGGCCTACAGCGGGCGCTTCGCGGCCTACCTCCCGACCGAGGGCCAGGAGGAGGTGTGGGCGAAGGGACCGCGCACCCGGCTGGTCAGCTCGATGGTGGCATCCGGCGTCCGGGCCGAACCGACGGCCGGCGGCTGGCGGCTGTCCGGCTCCTGGCTCTACGTCAGCGGCGTTGCGTTCGCCGACTGGGCCCTGGTCAGCTCCTCCCCGCCGCGCGAGGGCGACCGGAACGTGCGGGTGTTCGCCGTGCCCCGCGACGTGTTCACGTACGAGGACACGTGGGAGGCGATCGGCATGCACGCCACCGGCAGCCACACCCTCACGGTGGCCGACGCGTTCGTGCCGGAATACCGGGCGTTCGTCTGGGACGACATGCGGCAGGGCATCCTGGCAGGACCGGCCACCCGGGCCCAGTCCGCCCCGCTGTTCTCGGTGAACGGCCTGACCTTCGCCGCGCCGATCCTGGGCGCGGCTCGCGGCGCCCAGATCGTGGCCGGGCAGCACCTGTCCGTGCAGCCCAACGGTCCGCGCACCGCGGCAAGGGAATCGAGCCTGCTGTCCTTCGCACGCGCGGCGACGGAGATCGACGCCGCGGAGCTCCTGCTGCAGCGGGTTGCCGACACCGCCGACGGGGGCCTGCTCGACGACGGTCTGGCCGTCCGCAGCCACCGCGACGCAACCGTGGCGGTGCAGATCCTGATGGGCGCGGTGGACCGGCTGTTCGGGGTGACCGGCACCCGGGGCCAGGCCAGATCGCACCGCATGCAGCGGATCTGGCGCGATGTGCATACCGCCGGCTCGCATGCCGCCCTGCAGTTCGAACCGGCGGGCCTGGGCTACGCCCGGCGCCTGCTGTCGGCGTGA	MTAAGSWPDPAAVRVTAESAGRGAAEADASGRIGAETVEALTAAGFPSAFVPERWGGADATCGAVAKAVAEIGAGCASAAWIASLLAYSGRFAAYLPTEGQEEVWAKGPRTRLVSSMVASGVRAEPTAGGWRLSGSWLYVSGVAFADWALVSSSPPREGDRNVRVFAVPRDVFTYEDTWEAIGMHATGSHTLTVADAFVPEYRAFVWDDMRQGILAGPATRAQSAPLFSVNGLTFAAPILGAARGAQIVAGQHLSVQPNGPRTAARESSLLSFARAATEIDAAELLLQRVADTADGGLLDDGLAVRSHRDATVAVQILMGAVDRLFGVTGTRGQARSHRMQRIWRDVHTAGSHAALQFEPAGLGYARRLLSA	MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVRNNSELRRYIVPTYFVSSASKYLNENYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDRVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY	68.76	gnl|BL_ORD_ID|2288|hsp_num:0	3394			1107	1218	colistin A; colistin B
BGC0000232.1|Hatomarubigin_18 # 14523 # 14786 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.636	BGC0000232.1|Hatomarubigin_18 	14523	14786	+	Loose	400	23.483	IMP-53	29.58	3005463	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGGCTGCCCGGGAATTCACCCTCGACGACCTGCGTCGCATCCTGGTCGAAGCGGCAGGCGCCGACGAGTCCGTCAACCTCGACGTGGACATCCTCGACACCGACTTCGAGTCGCTCAACTACGAGTCGCTGGCCCTGTTGGAGACCGGCGGTCGCATCGAGCGTGAGTACGGCATCACGCTGGAGGACGACGCGCTGAGCATCGAGCACACGCCTCGCAAACTGATCGAACTGGTCAACGCCCACCTGAAGACGACGGGCTGA	MAAREFTLDDLRRILVEAAGADESVNLDVDILDTDFESLNYESLALLETGGRIEREYGITLEDDALSIEHTPRKLIELVNAHLKTTG	MSKLFVFFMFLFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNTDAYLIDTPFTAKDTENLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKYSFSGVSYWLVKKKIEVFYPGSGHAPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPKSAKLLMSKYSKAKLVVPGHSDIGDSSLLKLTWEQTVKGFNESKKSTTAH	35.51	gnl|BL_ORD_ID|3614|hsp_num:0	4683			171	384	
BGC0000232.1|Hatomarubigin_19 # 14789 # 15697 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.724	BGC0000232.1|Hatomarubigin_19 	14789	15697	+	Loose	600	30.8018	PRC-1	26.88	3007085	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	PRC beta-lactamase	ATGACCGCCACCAGCGGCGAACCGCGACCGGCGGTGGGCGCACGGGTACGCCGCATCCGGGTGAGTGCCGGGGACCTCGCGCTGTCGGGGCTGCTCGGCGAGCCGCTGGACGCACCGCCCCGGGCTGTCGTGGTCGCCCTGCACGGCGCTGGTATGAGCGCCGAGTACTTCCACGGCAGGGCCCATCAGGACGTGTCGCTGGCCACCCTGGGTACGCTGCTCGGCTTCTCCGTCCTTGCGCTGGACCGGCCGGGGTACGGCGCCTCCGCCGCGGATGCGCCGCACGGCAGGACCCTGGATGAACAGGCCGCGGCCGTCCATGCGGCCATGGCGTGGTTCGCCGACCGCCACGCGGTGGGCGCGGGGTTCTTCCTGCTGGGCCACTCTTACGGCGGCAAGGTCGCGCTGACTGCGGCCGCCCAGCCCGCCGGCGAGGACCTGCTGGGCGTCGACGTGTCGGGATGCGGCCAGGAGTACGCCGTGCCCGACGGCCTCCTCGACGACCGCCGCTCGGAGGACTGGACGAAGAACTGGGGTGCGCTGCGCTGTTATCCGCCCAGCACGTTCACGCTCAGCAAGTCGGTGGTCTCGCCGGTACCGAAACAAGAACGGGCCGAGGCACGGCGGTGGCCCGGCCGGTTCGCCCAGGTCGCCGCGGCGGTCCGTACGCCGGTCCGGTTCACCTTCGCCGAGCACGAGTCATGGTGGCGGCACGACGAGACCGCCGTCGGCGATCTGCGGGCCAGATTCACCTCCTCGCCGCGGGTGCTGGTGGAGCGCCAGCCGGACAGCGGCCACAACATCAGCCTGGGCTGGAGCGCGCGTTCGTACCACCTGAAGGCACTGGGCTTCCTGGAGGAGTGCCTGGCCTCGGACGCCCGGCGTCGCGAACGCGCACTGCATCACTGA	MTATSGEPRPAVGARVRRIRVSAGDLALSGLLGEPLDAPPRAVVVALHGAGMSAEYFHGRAHQDVSLATLGTLLGFSVLALDRPGYGASAADAPHGRTLDEQAAAVHAAMAWFADRHAVGAGFFLLGHSYGGKVALTAAAQPAGEDLLGVDVSGCGQEYAVPDGLLDDRRSEDWTKNWGALRCYPPSTFTLSKSVVSPVPKQERAEARRWPGRFAQVAAAVRTPVRFTFAEHESWWRHDETAVGDLRARFTSSPRVLVERQPDSGHNISLGWSARSYHLKALGFLEECLASDARRRERALHH	MRHLYRPLFVALALLAASHAPAAPSLETQVDAAAKSMMQTHAIPGMAIAISHKGQSHFFEYGVASLENGQTVDRHTLFELGSISKLFTATLGAYAEARGTLNLSDNASQYLPALQGSAFDHISLLDLATYTSGGLPLQFPDTVSNERQMLDYYRNWQAVYPPGTQRLYSNPSIGLFGHLAAASLAKPFQQLMEKDLLPQLSMQESYVRIPTEQMEHYAWGYRDDKAVRVTPGALDAEAYGLKSTAADVLRFIDANLHPDQLPAPLRQAISATHRGYYQVGDMTQALGWERYAYPISLEKLQAGNSAEMALQPQTVARFAAPKPAEGDLLLNKTGSTNGFGAYILLLPARDTGLVILANRNYPNAERVRLALQLLDAIEP	79.68	gnl|BL_ORD_ID|4774|hsp_num:0	5769			417	681	cefazolin; ceftriaxone; amoxicillin; benzylpenicillin; ampicillin; cefotaxime
BGC0000232.1|Hatomarubigin_20 # 15732 # 16517 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.695	BGC0000232.1|Hatomarubigin_20 	15732	16517	+	Loose	750	30.4166	mdtH	24.78	3001216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCGCAACAGGAGAAGCGTTCCGCACTCGTCACCGGAGCCACCAGCGGGATCGGCCTCGCGATCGCCCGGCTCCTGGGGAGGGAGGGCTACCGGCTGTACATCGGCTCGCGCAACGCCGACAACGTGGCCTCGACCGTGAAGCAGCTGCGCGACGAGGGCGTGGAGGTCGACGGCTCGGCCGTGGACGTCCGGTCGGGCACCGACGTGCGCGCCTTCGTGCAGGCAGCGGTCGACGCCTACGGGCCCGTCGACGTGCTGGTCAACAACGTCGGGCGCAGCGGCGGCGGGGTCACCGCGGACATTGAGGACGAGTTGTGGGAGGACGTCATCGAGACGAACCTCACCAGCGTCTTCCGGGTGACCCGCGAGGTGCTCAACACCGGCGGAATGCGCGGCAGGGACCGCGGCCGGATCATCAACATCGCCTCCACGGCCGGCAAGCAGGGCGTGGTGCTCGGCGCGCCGTACTCGGCCTCCAAGCACGGCGTCGTCGGCTTCACCAAGGCGCTGGGCAACGAGCTGGCGCCCACCGGCATCACCGTGAACGCAGTGTGCCCGGGCTACGTGGAAACGCCCATGGCGCAGCGGGTCCGGCAGGGCTACGCCGACGCCTACCACACCACCGAGGACGCGATCCTGGAGAAGTTCCAGGCCAAGATCCCGCTCGGCCGGTACTCAACCCCTGAGGAAGTGGCCGGCCTGGTCGGCTACCTGGCCTCCGACACCGCAGCCTCCATCACCTCGCAGGCGCTCAACGTCTGCGGCGGACTCGGCAACTTCTGA	MSQQEKRSALVTGATSGIGLAIARLLGREGYRLYIGSRNADNVASTVKQLRDEGVEVDGSAVDVRSGTDVRAFVQAAVDAYGPVDVLVNNVGRSGGGVTADIEDELWEDVIETNLTSVFRVTREVLNTGGMRGRDRGRIINIASTAGKQGVVLGAPYSASKHGVVGFTKALGNELAPTGITVNAVCPGYVETPMAQRVRQGYADAYHTTEDAILEKFQAKIPLGRYSTPEEVAGLVGYLASDTAASITSQALNVCGGLGNF	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	64.93	gnl|BL_ORD_ID|342|hsp_num:0	375			117	456	enoxacin; norfloxacin
BGC0000232.1|Hatomarubigin_21 # 16536 # 17471 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.685	BGC0000232.1|Hatomarubigin_21 	16536	17471	+	Loose	1800	31.9574	mdtC	32.76	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCACCCGTGAGGTCGAACACGAGATCATCGCCGACGCCCCGGCCGAAGCCGTCTATCGGCTCATCGCCGAGGTCGAGAACTGGCCGCGGATCTTCCCGCCGACCATCCACGTGGAGTACCTGGACCGGGGCGTCGACGACGAGCGCATCCACATCTGGGCGACCGCCAACGACGAGCCGAAGAACTGGACCTCGCGCCGCACCCTGTCCCCCGCCGACCTGCGGATCGACTTCCGCCAGGAGGTGTCGACACCGCCGGTGGCGGCCATGGGCGGCGCGTGGATCATCGAGCCCGTCACCGCGACCCGCTCGCGGATCCGGCTGCTGCACGACTACCGGGCGGTGGACGACACCCCGGAGAACCTGAAGTGGATCGACGAGGCCGTGGACCGCAACTCGCGCGCGGAGCTGGCCGCGCTGCGCACCAACGTCGAGCGCGCCCACGCCGAGGCCGAGCTCACCTTCTCCTTCGAGGACAGCGTCGCGGTGGACGGCGCGGTCAAGGACGCCTACGACTTCATCAACGAGGCATACCTGTGGTCCGAACGACTGCCGCACGTGGCCAAGGTGCGCCTGTCCGAGGACACTCCGGGGCTCCAGTCGCTGGAGATGGACACGCAGGCGCAGGACGGCTCGGTGCACACCACCAAGTCCTACCGGGTGACGTTCCCACACCACAAGATCGCCTACAAGCAGGTGACCCTGCCCGCACTGATGAACCTGCACACCGGCTACTGGACGTTCACCGAGAGCGACAGCGGCGTCACGGCGTCCTCGCAGCACACGGTGGTGCTCAACACCGCGAACATCGCCCGGATTCTCGGCGATGACGCCACCGTGGCCGATGCCCGGGAGTACGTGCGCAACGCGCTGAGCACCAACAGCCGGGCCACCCTCGGCCACGCGAAGGCGTACGCCGAGGGTCGGCGCTGA	MTTREVEHEIIADAPAEAVYRLIAEVENWPRIFPPTIHVEYLDRGVDDERIHIWATANDEPKNWTSRRTLSPADLRIDFRQEVSTPPVAAMGGAWIIEPVTATRSRIRLLHDYRAVDDTPENLKWIDEAVDRNSRAELAALRTNVERAHAEAELTFSFEDSVAVDGAVKDAYDFINEAYLWSERLPHVAKVRLSEDTPGLQSLEMDTQAQDGSVHTTKSYRVTFPHHKIAYKQVTLPALMNLHTGYWTFTESDSGVTASSQHTVVLNTANIARILGDDATVADAREYVRNALSTNSRATLGHAKAYAEGRR	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	30.34	gnl|BL_ORD_ID|1212|hsp_num:0	1315			669	843	novobiocin
BGC0000232.1|Hatomarubigin_22 # 17543 # 18340 # 1 # ID=1_22;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.733	BGC0000232.1|Hatomarubigin_22 	17543	18340	+	Loose	1300	25.409	mdtO	35.71	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGTCGCTGTGGTTGGTCCGGCCGCCACGGCCAGGAACTCCCGCGGCGTCCCGGCTGGCGGTCGACGAGCTGGACGCGTCGGAGAACGGGCGGGCGGACTTGTTCGTGCACCCGCGGGACCGGTTGCAGTACCTGGCCGCGCACATCGCGCTGCGCCGGGTGCTGGCGGCCCGTACCGGGTGCCCGCCCGGGGCACTGCGGCTGGGGCGGGAGCCCGGGCCGCCCGGGACGAATTTCAGCGGCCGGCCGGTGCTGGTGGACCCTCCGGCCCCGGTGCACTTCTCGCTGTCCCACAGCCACGGCCTGATCCTCATCGGCGCGGCGTCGGTGGTGGTCGGTGTGGACGTGCAGCGCGTGCCGACGCTGCAGACGGTGCAACTGTGCGGGCCCTCCTTGCACCCGGCGGAATGGAGCGAGTTGGCCAAGCGGCCCGCGGCGCGACAGCCTGCCGCCTTCGGGCGGCTGTGGGCCCGCAAGGAGGCGTACCTGAAAGGTCTGGGGACGGGCCTGCGGCGCAGCCCGGCGCTGGACTACGTGGGGGACGCCGCGGATGTCTGCGCTCCGCCCAAGCCGTTCGGCTGGATCGTCCGGGACGTGCCGGTCGGACCGCAGTACACCGCCGCCGCCGCCCTGGCCGTCGCCACAGAACCGACCATCACCCTGCGCTCATTGCCCGTGTCGTGCCTGTACGGCGGCAACGCGGGACAGCCGCTGTCCGCGGCACCGCTACTGGCTTGGAGGAGGAAAGGTTCATGGACGCTTCGGTGGTCATCGTGGGGGCGGGCCCTGCAGGCCTGA	MSLWLVRPPRPGTPAASRLAVDELDASENGRADLFVHPRDRLQYLAAHIALRRVLAARTGCPPGALRLGREPGPPGTNFSGRPVLVDPPAPVHFSLSHSHGLILIGAASVVVGVDVQRVPTLQTVQLCGPSLHPAEWSELAKRPAARQPAAFGRLWARKEAYLKGLGTGLRRSPALDYVGDAADVCAPPKPFGWIVRDVPVGPQYTAAAALAVATEPTITLRSLPVSCLYGGNAGQPLSAAPLLAWRRKGSWTLRWSSWGRALQA	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	38.80	gnl|BL_ORD_ID|1893|hsp_num:0	2056			1776	1902	acriflavine; puromycin
BGC0000232.1|Hatomarubigin_23 # 18295 # 19758 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.722	BGC0000232.1|Hatomarubigin_23 	18295	19758	+	Loose	550	339.732	Nocardia farcinica rox	46.15	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGACGCTTCGGTGGTCATCGTGGGGGCGGGCCCTGCAGGCCTGATACTCGCCGGGGAACTGCGCCTGGCGGGCGTCGGCGTGACGGTCCTCGAACGCCTGGAACAGCGCACCGGCGAGTCCCGCGGAATCGGCTTCACCATCCGCACCATGGAGGTGTTCGACCAACGCGGGGTGCTGCGCCGACTCGGCCCGATCGAGACGGCCACGGCCGGGCACTTCGGCGGTCTGCCGCTGGACCTGGGGGTGCTGGGGGCGGCGCACCGAGCTGCTCGCACCGTGCCGCAGTCGGTGACCGAACAGGCCCTGGAGGGATGGGCCAGGGAGTTGGGCGCCGACATCCGGCGCGGGCAGGAGGTCCAGGCGCTCGAGGACACCGGTGACGGCGTGACCGTCACGGTGGCCCGCGGCGACAACCGGGAAATACTTCGAGCCCGCTACCTGGTCGGCTGCGACGGCGGGCGCAGCACCGTGCGCAAGCTGGCCGGGTTCGACTTCCCGGGCACCGACGCCACGACCGAGATGCTGTTGGCAGACGTCCGCGGGGTGGAACTCGAACCGCGGATGAGCGGCCAGCAGATCGGCAACGGCTTCCTGATGGTCGCAAAGCTGCCCGGCGGCATCCACCGGCTGATCGTGGGCGAACGCGGCATCGCACCGCGCCGACGTACCGGCCCCCCGCCGTTCTCCGAGGTCGCCGACCTGTGGAAGCGACTGACCGGCAGTGACATCTCGCACGCCGAGCCGGTGTGGGTCAGCGCCTTCGGCGACGCCGCGCGGCAGGTCACCGAGTACCGGCGCGGTCGCGTGCTGCTGGCCGGCGACGCCGCCCACGTTCACCTGCCCGCCGGCGGGCAGGGCATGAACACCAGCATCCAGGACTCCCACAACCTGGGATGGAAGCTGGCGTCAGTGCTGGCCGGCCACGCCCCGGAGGCGCTGCTCGACACCTATCACAGCGAGCGCCACGAGGTGGGGCGGCGGCTGTTGGTCAACACGCGGGCGCAGAGCCAGTTGATCCTGGGCGGCGAGGAGGCGCAGCCGCTGCGCGAGGCGCTGTCGGAGCTGCTCCAGTACCCGAACGTCGTACGCCACTTGGCGGCCAAGGCCAGCGGTCTGGACATCCGCTACGACGTCGGCGGTGGCACCAACCCGCTGCTGGGCCGCCGGCTGCCGCACCTTCCGTTGACCACCGGCGCCCGTAGGACCAGCAGCACCGAGCTGCTGCGGGCCGGCCGCGGCGTGCTGCTGGACCTCGGTGACAATGCCAGGCTGCGTGACCGCGCAACGCCGTGGCGGAACCGGGTCGACGTCGTGACCGGAACCGCGGACCCCGAGCACGCTCTCCCGGGCGGCACCACGGCGGCGCTGGTACGCCCCGACGGTCATGTGGCGTGGGCCGCACCCGGCAGCCACCAGGACCTGGCGACCTCGCTGACCCGCTGGTTCGGGCCGGCTACATGA	MDASVVIVGAGPAGLILAGELRLAGVGVTVLERLEQRTGESRGIGFTIRTMEVFDQRGVLRRLGPIETATAGHFGGLPLDLGVLGAAHRAARTVPQSVTEQALEGWARELGADIRRGQEVQALEDTGDGVTVTVARGDNREILRARYLVGCDGGRSTVRKLAGFDFPGTDATTEMLLADVRGVELEPRMSGQQIGNGFLMVAKLPGGIHRLIVGERGIAPRRRTGPPPFSEVADLWKRLTGSDISHAEPVWVSAFGDAARQVTEYRRGRVLLAGDAAHVHLPAGGQGMNTSIQDSHNLGWKLASVLAGHAPEALLDTYHSERHEVGRRLLVNTRAQSQLILGGEEAQPLREALSELLQYPNVVRHLAAKASGLDIRYDVGGGTNPLLGRRLPHLPLTTGARRTSSTELLRAGRGVLLDLGDNARLRDRATPWRNRVDVVTGTADPEHALPGGTTAALVRPDGHVAWAAPGSHQDLATSLTRWFGPAT	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	102.96	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1419	rifampin
BGC0000232.1|Hatomarubigin_24 # 19901 # 20665 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.706	BGC0000232.1|Hatomarubigin_24 	19901	20665	+	Loose	400	82.8037	Escherichia coli fabG mutations conferring resistance to triclosan	32.35	3004049	protein variant model	Y151V	n/a	disinfecting agents and antiseptics	antibiotic target alteration	antibiotic resistant fabG	ATGACCGCTGAGTCCGTACCCGTCGCCGTTGTCACCGGAGCCAACAAAGGAATCGGCCGGGAGATCGCCCGGCAGCTGGCCGTGCGCGGTCTGGTCGTCTACCTGGGAGCCCGCAGCGAGCGACGCGGCCGGGAGGCCGAGAGCGCGCTGCGCGCCGACGGCCTCGACATCCGCTTCCTGCACCTGGACGTCACCGACGAGACCTCCGTGGCGCTGGCCGCAAAACGGCTGGAGGACGAGGTGGGGGTGGTGCACGCACTGGTCAACAACGCCGGTGTCGGCGGCCCCTACCTGCCCCCCAGTAGGACCTCGGCTGCGCAGGTGCGGGAGACCTACGACACCAACGTCTTCGGTGTCATCACTGTGACCAACGCACTGCTGCCGCTCCTGCGCCGGGCAGGGTCGGCCCGGATCGTCAACGTCAGCAGCGCGGTCGGCTCGCTGTCCGCGGCGGCGGCGAACGTCGACCCGACCGGGGTGCACCTGCCCGGCGAGTTCCCGACGCTGCTGGCGTACAACACGGCCAAGGCCGCGCTCAACTCGGTCACCGTGACGTACGCCAACGAACTGCGCGGCACCGGCATCCTCGTCAACGCCGCCTCCCCGGGCTTCGTGGCGACCGACATCAACGGCCATCACGGCATCCTCACCCCCGAGCAGGGCGCGCACATCCCGGTGCTCCTGGCCACCCTCGGCGAGGACGGGCCGACGGCCACCTTCCTGGGCGAGAACGGCACGCCCGAAGGACAGGTGCTGGACTGGTGA	MTAESVPVAVVTGANKGIGREIARQLAVRGLVVYLGARSERRGREAESALRADGLDIRFLHLDVTDETSVALAAKRLEDEVGVVHALVNNAGVGGPYLPPSRTSAAQVRETYDTNVFGVITVTNALLPLLRRAGSARIVNVSSAVGSLSAAAANVDPTGVHLPGEFPTLLAYNTAKAALNSVTVTYANELRGTGILVNAASPGFVATDINGHHGILTPEQGAHIPVLLATLGEDGPTATFLGENGTPEGQVLDW	MNFEGKIALVTGASRGIGRAIAETLAARGAKVIGTATSENGAQAISDYLGANGKGLMLNVTDPASIESVLEKIRAEFGEVDILVNNAGITRDNLLMRMKDEEWNDIIETNLSSVFRLSKAVMRAMMKKRHGRIITIGSVVGTMGNGGQANYAAAKAGLIGFSKSLAREVASRGITVNVVAPGFIETDMTRALSDDQRAGILAQVPAGRLGGAQEIANAVAFLASDEAAYITGETLHVNGGMYMV	104.10	gnl|BL_ORD_ID|4713|hsp_num:0	2681			15	564	triclosan
BGC0000232.1|Hatomarubigin_25 # 20662 # 21966 # 1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.739	BGC0000232.1|Hatomarubigin_25 	20662	21966	+	Loose	1000	99.3673	efpA	34.0	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACCGGATCCCGTCCCGCGCCTGCCGGCCGCCCGGTGGTGCGAGAGCGCTGGGACGCACGCCGGCGGATCCTGCTGGCGGTGCTGTCCGGCAACATGCTGCTGGACGCGGTCGAGGTGTCGGTGGTGCTCATCGCCCTGCCCACGATCGCCGACCGGCTGGGCCTGAGTCCGCTGGCCGCCCAGTGGCTGATGAGCGGCTTCGCTCTCGGCTTCGCCGTGCTGCTGCCGCTCGGGCCGGTGCTCGCCGGCCGGGTCGGGCGTCGTCCGGTCTATCTCGGCGCGATGCTGCTGTTCGGCCTGGCCTCAGTGGTCGGCGGGCTGGTGGACGGTCTGGCGGTGCTGGTGGTCATCCGGCTGCTGAAGGGGGCTTGCGCGGCCCTGACCGCCCCGATGGGACTGGCCATCATCAGCGACGTCTTTCCCGACGGGCCGCAGCGCCGGCGAGCCCTCGCGGTGTACTCGTTGTTCGGCGCCGGCGGCTTCACCTCCGGACTGCTGCTCGGCGGGGTGCTGCTGGAGGCGGGCTGGCGCTGGGTCTTCGTCTTCCCCGCGCCGGTCGCCCTGGTGCTGTTCCTGGGCGGCATGCGCGTGCTGCCCGGGACCCACAGCGGGGCACGGCCGGGGCTGCCGCGTCCGGCGCTGCTGCGAGAGGGCTCCCTGCTGCGCTCGGCACTGGGGGCGGCCATACTCAACGGCACCTATCAGAGCCTGCTGCTGGTGATGGTCTTCCAGTCCATGGGCGGCTTCGGCTGGGCACCGTGGTTCACCGCACTGGCGCTGCTGCCCGCGTGCCTGCCGCTGGCGGTGACCATCCCCTTCGCCGGGCGACTGATCGCCCGGTACGGCGGCGGCCGGCTGATCACGCTCGGCGCGCTCTTCCCCCTGCTGGGCTACGGACTGTATCTCGCCCGGCCCGAGGGCAGCCCGTACGCGCTGGGGATGCTTCCGGCGCTGCTGCTGGTGGAGGCCGGCTTCTGCTGCTCGTTCGTGGCCCTCAACATGCGCGCCACCGCCTCGCTCGCCCCGGCCGACCGCGGCGCGGCGGTGTCGCTGTACCAGATGTGCGTGCAGTTGGGCGCCGCGGTGCTGCTGCCGCTGGTCGCGCTGTTGCTCACCCACGGCGACGGGCCGCGCCCGGCGCTGACCCTCATCACGGCGGCCGGCGCGCTCGGCCTGCTGGTCCCACTCGCCGTACACCGGGTTTCCGCCCGGTCCGACCCCGGCCCTGACCCGCGAGCCCCCGACGGGCCCGCGCCCCACCCGTCCCGCACACCACCACAAGGAGACCTCCCCCATGGCTGA	MTGSRPAPAGRPVVRERWDARRRILLAVLSGNMLLDAVEVSVVLIALPTIADRLGLSPLAAQWLMSGFALGFAVLLPLGPVLAGRVGRRPVYLGAMLLFGLASVVGGLVDGLAVLVVIRLLKGACAALTAPMGLAIISDVFPDGPQRRRALAVYSLFGAGGFTSGLLLGGVLLEAGWRWVFVFPAPVALVLFLGGMRVLPGTHSGARPGLPRPALLREGSLLRSALGAAILNGTYQSLLLVMVFQSMGGFGWAPWFTALALLPACLPLAVTIPFAGRLIARYGGGRLITLGALFPLLGYGLYLARPEGSPYALGMLPALLLVEAGFCCSFVALNMRATASLAPADRGAAVSLYQMCVQLGAAVLLPLVALLLTHGDGPRPALTLITAAGALGLLVPLAVHRVSARSDPGPDPRAPDGPAPHPSRTPPQGDLPHG	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	81.89	gnl|BL_ORD_ID|2188|hsp_num:0	2427			60	660	rifampin; isoniazid
BGC0000232.1|Hatomarubigin_26 # 21959 # 22990 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.684	BGC0000232.1|Hatomarubigin_26 	21959	22990	+	Loose	300	25.0238	dfrA3	25.33	3003105	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGGCTGACCAATCGCCCGAGACGCAGGTGCATCCCGGCCCGATCATGGGCCTGATGGCCGGCTACTGGCAGGTGAGGATGTTGCTGGCGGCCCTGGAGCACGACATCTTCACCGAGCTGTCGAAGGGGCCGGCCACCTCCGGCGAGGTCGCCGACCGCATGGGCCTGGTCGAGCTCGGCACACATGACCTGCTCACCGGCCTCGGCCACCTCGGCCTGCTCCAGGTCGCCGACGGCAGGTTCGCCAACTCCCCCCTGGCCGACCGCTTCCTGGTCCGCGGAGGCCCGGAATTCCTCGGCGGATACCTGCGGTTCTGCGAGCAGGAGCTGAACCCGGCCTGGGACGGCCTGGCGACCTCGCTGCGTACCGGCCGGCCGACCAACCGCGCCGCGGTCGTCGGCAACCCGTACGACACCCTGTACTCCGACCCCGACGCCACCGACGGCTTCCTGGACAGCATGGACCTGCTCAGCACTCCTATCGGACTGGCCATCAGCCGGTACGACTGGAGCCAGTACTCCTCTTTCATCGATGTCGGTGGTGCCCGCGGCAACTTCGCCCACCAGGTGGTCACCGAGAACCCGCACCTGACCGCCGGTGTCTTCGACCTGCCCCCGCTGGAGGGCACCTTCAAGCGGCACATCGAGCGGCTGGGCGCGACCGCCTCGGGAATCAGCTTCCACGGGGGCGACTTCTTCAAGGACAAGCTCCCGAAGGCCGATGTGATCGTCCTCGGCCACGTGCTGCACAACTGGGGTGTTGAAGACCGCGTCCAGTTACTGAAGAACGTCTACGACGCGGTCCGGCCGGGTGGCGCCGTGTTCGTTTACGACCCGATGGCCGGCGGCGAGCAGCCGTCCCTGCACGCGGTGTTGGCGGGGCTGGCGATGCTGGTGTGGTCCCGGGGCGGTCACGAGTACTCCGTCGAGGAACTGCACGGCTGGCTACGGGAGGCGGGTTTCTGGCCGGAGACCGCCGAGGTCCCCGGCCTGCACGAGGACGTGCTGGTCATCGGCCACAAGGACGCCTGA	MADQSPETQVHPGPIMGLMAGYWQVRMLLAALEHDIFTELSKGPATSGEVADRMGLVELGTHDLLTGLGHLGLLQVADGRFANSPLADRFLVRGGPEFLGGYLRFCEQELNPAWDGLATSLRTGRPTNRAAVVGNPYDTLYSDPDATDGFLDSMDLLSTPIGLAISRYDWSQYSSFIDVGGARGNFAHQVVTENPHLTAGVFDLPPLEGTFKRHIERLGATASGISFHGGDFFKDKLPKADVIVLGHVLHNWGVEDRVQLLKNVYDAVRPGGAVFVYDPMAGGEQPSLHAVLAGLAMLVWSRGGHEYSVEELHGWLREAGFWPETAEVPGLHEDVLVIGHKDA	MLISLIAALAHNNLIGKDNLIPWHLPADLRHFKAVTLGKPVVMGRRTFESIGRPLPGRRNVVVSRNPQWQAEGVEVAPSLDAALALLTDCEEAMIIGGGQLYAEALPRADRLYLTYIDAQLNGDTHFPDYLSLGWQELERSTHPADDKNSYACEFVTLSRQR	211.73	gnl|BL_ORD_ID|470|hsp_num:0	511			138	351	trimethoprim
BGC0000232.1|Hatomarubigin_27 # 23212 # 24003 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.716	BGC0000232.1|Hatomarubigin_27 	23212	24003	+	Loose	400	25.7942	MexL	25.0	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGATCGAAAACAGTGTTGGCGTCGTCACCGGCGCGGCCAGCGGCATCGGCAAGGCCATCGCAGTGGCGCTGGTCGAGGCAGGCGCACGTGGCGTCGTGGTCTCCGACATCGATGGCGAGGGCGCCGAGAAGGTGGCCGCGTCGATCGGTGACGCCGCGATCGCGGTGCGGGCCGACGTCACCGACGAGGCCGCCGTCCGGGCGCTGGTGGCGCGCGCCCGGGAACGGTTCGGCACCATCGACCTGTTCGTCTCCAACGCGGGCCTTCCCGTGACAGGCGGGTACGAGACGTCGGACGAGGACTGGAAGCGCGCCCTCGACGTCAACTTGATGGCGCACGTGTACGCCGCGCGCGCGGTGCTCCCGACGATGCTGGCGACCGGCCGCGGCCACCTGCTGCAGACGATCGCGGCGTGCGGGGTGCTCACCGCTTTCGGAGCGGCGGCGTACTCGGTCGCCAAGCAGGGCGCGGTGGCGTTCGCCGAGTACATCGCGATCGAGCACGGCGGCCAGGGCATCGGCGTCTCGTGCCTGCTGCCGCAGGCGGTCGACACGCCGATGCTGGCCGCCGGTGTCAAGAGCAGCGAGCAACTTGCGCTGCTCAAAGCGCACTCGGAGGTGCTGGAGCCGGGGCAGGTGGCGGCGGCCGCCCTGCAGGGAGTGGAGGAGAACCGGATACACATCCACACCCACACCGGCTCGGCGGAGTCCTTCCGACTGCGCGCCCAGGACCCCGACCGGTGGGTGGCCGAGATGCGGGCGATCCGTTCCGGCCGGCCCGCCGCCTGA	MKIENSVGVVTGAASGIGKAIAVALVEAGARGVVVSDIDGEGAEKVAASIGDAAIAVRADVTDEAAVRALVARARERFGTIDLFVSNAGLPVTGGYETSDEDWKRALDVNLMAHVYAARAVLPTMLATGRGHLLQTIAACGVLTAFGAAAYSVAKQGAVAFAEYIAIEHGGQGIGVSCLLPQAVDTPMLAAGVKSSEQLALLKAHSEVLEPGQVAAAALQGVEENRIHIHTHTGSAESFRLRAQDPDRWVAEMRAIRSGRPAA	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	124.06	gnl|BL_ORD_ID|4690|hsp_num:0	2219			60	216	erythromycin; tetracycline; triclosan
BGC0000232.1|Hatomarubigin_28 # 24125 # 24706 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.679	BGC0000232.1|Hatomarubigin_28 	24125	24706	+	Loose	600	27.335	msr(G)	25.0	3007042	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGGACGAGGAAAAACTGCGGCTCGTCGTGATCATCGGATCGGCCCGCGAGGGCCGCACCGGTCCGGCCGTTGCGAGGTGGTTCGTCGAGGAGACCAGGTCTTCCGGGCTGTTCGATGTGGACGTGATCGATCTCGGCGACGTCGAACTGCCCCTGACACTGACGCGGGTGCCCGGCGCCGAGTTCACGCGGGTGCTCGCCGACCTCGGCGCACGCCTGGAGTCGGCCGACGCATTCGTCGTGATCACCCCCGAGTACAACCACAGCTTCACCGCACCGCTGAAGAACCTGATCGACTGGCACCGCACCCAGTGGCAGGCCAAGCCGGTTGGCTTCGTCAGCTACGGCGGGCTGTCCGGCGGGCTGCGGGCCGTGGAGCAGCTGCGCCAGGTCTTCGCCGAACTGCACGCCGCCACGATCCGTGACACCGTCAGCTTCCACCAGGTCTGGGAGCGGATCGGCGAGGACGGCCGGCTGAGCAGCTCCGACGCCACGATCCCGGCCAAGGTGATATTGGAGAAGCTGCAGTGGTGGGCTGCGGCACTGAGGGACGCCCGCGTGCTGCGGCCCTATTCCGCCTGA	MDEEKLRLVVIIGSAREGRTGPAVARWFVEETRSSGLFDVDVIDLGDVELPLTLTRVPGAEFTRVLADLGARLESADAFVVITPEYNHSFTAPLKNLIDWHRTQWQAKPVGFVSYGGLSGGLRAVEQLRQVFAELHAATIRDTVSFHQVWERIGEDGRLSSSDATIPAKVILEKLQWWAAALRDARVLRPYSA	MEQICFELENVEVTYLDKEVLKIERLAVHQFDRIGIVGKNGAGKSTLLKLLAGIIKPTTGKVNRLVENGYFEQLETPSVRDADPVLLGKLDVPKDSNQLSGGEQTRMKLAKLFTHYYEALLIDEPTTHLDQEGISFLLDELRYYYGALVLISHDRSVLDELVTTIWEVHEGKVRIYSGNYSDYMAQKKLEREQQSQAHEQFIKEKSRLEKAAQEKMKKAEKVAQAGRLSKKDANAKPDKSFMTKSKGTSQKAMQRAAKAIEQRMEKLQEVDAVKEDRQINFHQSRNLELHNKFPIMADRFTLQVDNKVLLNEVSFQMPLGKKIAISGKNGAGKSTLLHHIAINAPGLTISPKAKIGYFRQMSYQYTRDETVLEFLKNRSEYDERFLRSVLHSMLFVGTDILKSVKSLSGGEAIRLQLCQLFLGEYNILLLDEPTNFLDIYAIEALERFITAYKGTIIFVSHDRRFIDCVADCIYFIEDQQLKLRG	39.79	gnl|BL_ORD_ID|4749|hsp_num:0	5743			141	321	erythromycin; azithromycin
BGC0000232.1|Hatomarubigin_29 # 24769 # 25902 # 1 # ID=1_29;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.768	BGC0000232.1|Hatomarubigin_29 	24769	25902	+	Loose	2000	26.5646	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	27.27	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGTGCGGCCACCGCGCACCGTGGCCGGACGCCGGGCTGATCCGGGCCGCTGCGGCCACCGCCGGCCGCCACGCCTTGCATGCGGATGTGTCGGGGAGCCTGTCTCCGGAGACGGTCGCGGCGCTGGCCGCGGCCGGCTTCCCCGGCTGTTTCGTGCCGGAACCGCTGGGCGGGGCCGGCGCCACGTTCGGCGCGGCGACGCGGGCAGTGGCGGCGATCGGCGAGGAGTGCGCCGCCGCTGCCTGGACCGCGTCTGTGTGGGCGTACAGCGGTCGGGGCGGCGCCTTCCTGCCGGCCGAGGGGAGGGCGGAGATATGGGCAAAGAACCCGCAGGCGCGGCTGGTCAGCTCGACGGCCGCCTGTGGGGTGCGGGCGGCCCCGGTGGCCGGGGGCTGGTTGCTCTCCGGCGCGTGGCGCTGCGCCGGCGGAGCGGAGTCTGCCGACTGGGCGCTGCTCAGCTCGGCGGTGCCGCGCACCGGCGACCGGTCGGTGCTGATGTTCGCCGTGGCCCGGGGCTCCTTCACCCTCGCCCACTGCGGCGAGTCCTCGATGCTGGGCATCCGGGCCGCCGGCCGCCAAACGCTGGTCGTGGAGCGCGCGTTCGTCCCGGAGCACCGGGCCTTCGTGTGGGACGACATGCGGCGGGGCCGCCCGGCCGGTCCGGCGACCACCGCCCGCCTGGCCCCCCTGTCCGCAGTGACCGGCCTGGCGTTCGCGACGCCGATCCTGGGCGCGGCACGAGGCGCCCTGCGGCTGGCCGAGGAGCGCCTCGCGGTGCGGCCGCGCCGGAGCGCGGCGAGGAGTTCGGTACGGATGCCGGGCCGCGTCGCGTTCGCCCGCTCGGCCGCCGAGATCGACGCGGCGGCCCTCCTGCTGTTCCGGGTGGCCGAGGACGCCGACATGTGTCGGTCCGACGACACACCGACCGCACGCGGCCGGCGCGACAGCGCCCTTGCGGCGGAACTACTGACAGCTGCGGTGGACCGGCTGTTCCGGTCGGCCGGAAGCCAGGGCCGGGCGTCCTCCCACGCGATGCAGCGCATCTGGCGGGATGTGCACGCCGCCGGCGCGTACAACGCCCTCCGGTTCGAGTCCGCCACGATCGGCGACGCACGCGGGCTGCTGTCCGTCTGA	MCGHRAPWPDAGLIRAAAATAGRHALHADVSGSLSPETVAALAAAGFPGCFVPEPLGGAGATFGAATRAVAAIGEECAAAAWTASVWAYSGRGGAFLPAEGRAEIWAKNPQARLVSSTAACGVRAAPVAGGWLLSGAWRCAGGAESADWALLSSAVPRTGDRSVLMFAVARGSFTLAHCGESSMLGIRAAGRQTLVVERAFVPEHRAFVWDDMRRGRPAGPATTARLAPLSAVTGLAFATPILGAARGALRLAEERLAVRPRRSAARSSVRMPGRVAFARSAAEIDAAALLLFRVAEDADMCRSDDTPTARGRRDSALAAELLTAAVDRLFRSAGSQGRASSHAMQRIWRDVHAAGAYNALRFESATIGDARGLLSV	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	31.79	gnl|BL_ORD_ID|4719|hsp_num:0	2914			2607	2739	rifampin
BGC0000232.1|Hatomarubigin_30 # 25943 # 26545 # -1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.648	BGC0000232.1|Hatomarubigin_30 	25943	26545	-	Loose	210	45.8246	Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline	29.32	3003378	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGCGTACGGGATATGCTCTGGCGAAGCGCTGCAACCGAACGGCGTGCATCCGTAAGTGGTTCATGGTGCGAACTTTATGGCCGATAAGGTACGCTGTCGGTGTGGCTAAGCATGATGAAGGCCAGATGGGGATTGTGAGCGCACTGGTAAGGTCCTCGTTCCTGGTGGACTCCGTGTATGCCCGGGCTGCCCGGGAGTACGGCCTCACGTCTCAGCAGGGCCAACTACTGTGCGTACTGATGGGACAGCCCTACGGAATGGGCGAGTTGAGCTCCGTGCTGGGGCTGGCGAAGTCCAGTCTCAGCGGTCTGGTCGACCGCACCGAGAGCAACGGCCTGGTCCGGCGCGAAGCCGATCCGCAGGACAGCCGTGCGGTGCGGGTGGCGCTCACCGGCCGGGGAGCGCGGCTCGCCGACCGCTTCTACACCGATGCCTGCCGCCGCATACAGGAACTGTCGACCGGGCTCGGTGATGACGAGCGCGATACGCTGGCCCACCTGCTGGGCCGCCTTGTGCTGGACAACAAGGTTCCGGTGGTCTTCGTCGGTGACCGGACCGACGCGACCCAGGACGGGAGCGAACTCGATACGACCGCCTGA	VTRTGYALAKRCNRTACIRKWFMVRTLWPIRYAVGVAKHDEGQMGIVSALVRSSFLVDSVYARAAREYGLTSQQGQLLCVLMGQPYGMGELSSVLGLAKSSLSGLVDRTESNGLVRREADPQDSRAVRVALTGRGARLADRFYTDACRRIQELSTGLGDDERDTLAHLLGRLVLDNKVPVVFVGDRTDATQDGSELDTTA	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP	138.89	gnl|BL_ORD_ID|1984|hsp_num:0	431			30	429	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000232.1|Hatomarubigin_31 # 26627 # 26824 # 1 # ID=1_31;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	BGC0000232.1|Hatomarubigin_31 	26627	26824	+	Loose	800	24.2534	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid	44.44	3003461	protein variant model	V18A	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant ndh	ATGAGTGCAACAGTCGCGGTCGTCGGCGGAGGGTACGGCGGCGCCGCCGTCGCCAAGGCTCTCGAAGCCGAAGCCGATGTCATCCTCATCGACCCCCGGGACGCGTTCGTCAACGCGGCCGCCTCGTTACGCGCGCTGACCCAGCCCGACTGGGCGGGCAACGTCTTCTACCCCTTCGACACGCTGCTCACCCAGGGC	MSATVAVVGGGYGGAAVAKALEAEADVILIDPRDAFVNAAASLRALTQPDWAGNVFYPFDTLLTQG	MSPQQEPTAQPPRRHRVVIIGSGFGGLNAAKKLKRADVDIKLIARTTHHLFQPLLYQVATGIISEGEIAPPTRVVLRKQRNVQVLLGNVTHIDLAGQCVVSELLGHTYQTPYDSLIVAAGAGQSYFGNDHFAEFAPGMKSIDDALELRGRILSAFEQAERSSDPERRAKLLTFTVVGAGPTGVEMAGQIAELAEHTLKGAFRHIDSTKARVILLDAAPAVLPPMGAKLGQRAAARLQKLGVEIQLGAMVTDVDRNGITVKDSDGTVRRIESACKVWSAGVSASRLGRDLAEQSRVELDRAGRVQVLPDLSIPGYPNVFVVGDMAAVEGVPGVAQGAIQGAKYVASTIKAELAGANPAEREPFQYFDKGSMATVSRFSAVAKIGPVEFSGFIAWLIWLVLHLAYLIGFKTKITTLLSWTVTFLSTRRGQLTITDQQAFARTRLEQLAELAAEAQGSAASAKVAS	14.25	gnl|BL_ORD_ID|1990|hsp_num:0	1203			48	129	isoniazid
BGC0000232.1|Hatomarubigin_8 # 3976 # 5247 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000232.1|Hatomarubigin_8 	3976	5247	+	Loose	750	181.03	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.06	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAATGGTCGTCGCGCGGTCATCACAGGCCTGGAGGTCCTGGCCCCGGGTGGCGTCGGCGCCAAGGACTTCTGGTCGCTGCTGAGCGAGGGGCGTACCGCGACGCGGGGCATCACTTTCTTCGACCCGGCGCCGTTCCGCTCCCGGGTGGCGGCCGAGATCGACTTCGCCCCAGAGGCACATGGCCTCCATCCGCAGGAGATCCGGCGAATGGACCGTGCCGCGCAGTTCGCGGTCGTCACCGCGCGCGGTGCGCTGCGTGACAGCGGCTTGGAGTTGGAGGGCTACGCCCCGCACCGGGTCGGCGTGACGGTGGGCACGGCGGTCGGCGCGACGATGGGCCTGGACGAGGAGTACCGGGTGGTCAGCGACGGCGGCCGGCTGGACCTCGTCGACCACACCTACGCGGTGCCGCACCTGTACAACTACCTGGTGCCCAGCTCCTTCGCGGCCGAGGTGGCCTGGGCGGTGTCGGCCGAGGGGCCGAACTCGGTGGTGTCGACCGGGTGCACCTCTGGCATCGACGCGGTGGGCTACGCAGTCGAGTTGATCCGCGAGGGATCGGCGGACGTGATGGTCGCCGGCGCCTCGGACGCGCCGATCTCTCCGATCACCATGGCGTGCTTCGACGCGATCAAGGCGACCACGCCGCGGCACGACGAACCGCAGAAGGCCTCCCGCCCGTTCGACGGCACCCGCAACGGGTTCGTGCTCGGGGAGGGGGCGGCGTTCTTCGTGCTGGAGGAGTTGGAGTCCGCCCGGCGGCGCAACGCACACATCTACGCCGAGATCGCCGGGTACGCCACGCGCAGCAACGCCTACCACATGACCGGGCTGCGTCCGGACGGAGCGGAGATGGCCGAGGCGATCCGGTCCGCGCTGGACGAGGCGCGGATGAACCCCGAGGAGATCGACTACATCAACGCACACGGCTCGGGCACCAAGCAGAACGACCGGCACGAGACGGCGGCGTTCAAGAAGAGCCTGGGCAGCCACGCCCGCGCCACACCGGTCAGCTCGATCAAGTCGATGGTGGGCCACTCGCTGGGCGCCATCGGCTCCATCGAGATCGCCGCCTCGACCCTGGCCATGGCGTACAACCTGGTGCCGCCGACGGCGAACCTTCACACGCCCGACCCCGAGTGCGACCTGGACTACGTGCCGCTGACCGCCCGGGAACACCGGACCGACACGGTACTGACCGTGGGCAGCGGCTTCGGCGGCTTCCAGAGCGCGATGGTGCTGGCCCGCCCCGAAAGGAATGCCGCATGA	MNGRRAVITGLEVLAPGGVGAKDFWSLLSEGRTATRGITFFDPAPFRSRVAAEIDFAPEAHGLHPQEIRRMDRAAQFAVVTARGALRDSGLELEGYAPHRVGVTVGTAVGATMGLDEEYRVVSDGGRLDLVDHTYAVPHLYNYLVPSSFAAEVAWAVSAEGPNSVVSTGCTSGIDAVGYAVELIREGSADVMVAGASDAPISPITMACFDAIKATTPRHDEPQKASRPFDGTRNGFVLGEGAAFFVLEELESARRRNAHIYAEIAGYATRSNAYHMTGLRPDGAEMAEAIRSALDEARMNPEEIDYINAHGSGTKQNDRHETAAFKKSLGSHARATPVSSIKSMVGHSLGAIGSIEIAASTLAMAYNLVPPTANLHTPDPECDLDYVPLTAREHRTDTVLTVGSGFGGFQSAMVLARPERNAA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.68	gnl|BL_ORD_ID|1968|hsp_num:0	1943			312	1245	isoniazid
